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ABSTRACT 
The mechanisms of the anticonvulsant activity of cannabidiol 
(CBD) and the central excitation of I:. 9 -tetrahydrocannabinol (I:. 9- THC ) 
were investigated electrophysiologically with conscious, unre-
strained cobalt epileptic rats.. The well-known antiepileptics I 
trimethadione I ethosuximide and phenytoln, were included as 
reference drugs. Direct measurements were made of spontaneously 
firing, epileptiC potentials from a primary focus on the parietal 
cortex and convulsions were monitored visually.. Ethosuximide and 
trirnethadione decreased the frequency of focal potentials, but 
phenytoin and CBD exerted no such effect. A.lthough CBD did not 
suppress the focal abnormality I it abolished jaw and limb clonus. 
Consequently I CBD may produce its anticonvulsant effect by 
9 depreSSing seizure spread in the eNS.. In contrast, I:. -THe 
markedly increased the frequency of focal potentials I evoked 
generalized bursts of polyspikes and produced frank convulsions .. 
ll-OH-I:. 9 -THC I the major metabolite of ~ 9 -THC displayed only 
one of the excitatory properties of the parent compound: production 
of bursts of polyspikes. In contrast to !::. 9 -'rue and its II-OR-meta-
bolite I CBD I even in very high dose S I did not induce any excitatory 
effects or convulsions. The present study provides the first evidence 
that CBD exerts anticonvulsant activity against the motor manifes-
tations of a focal epilepsy, and that the mechanisnl of the effect may 
involve a depression of seizure spread in the eNS. 
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INTRODUCTION 
Both A 9 -tetrahydrocannabinol (~ 9 -THC) and cannabidiol (CBD) 
have anticonvulsant activity (Garriott et al. I 1968; Izquierdo and 
Tannhauser I 1973; Karler et al. I 1973, 1974Q,Q,g; Karler and 
9 Turkanis, 1976,£,Q; Consroe et al. I 1976), but fy. -THC is more 
toxic than CBD (Hollister I 1973; Perez-Reyes et al., 1973; Karler 
et al., 1974a, g). The potential toxicity of t:. 9 -THC derives not 
only from its psychic and cardiovascular effects in humans I but 
also from its CNS depressant and excitatory properties in animals. 
The CNS depressant effect, which has been described in terms of 
motor toxicity, is important in defining the selectivity of the anti-
convulsant activity relative to the neurotoxic activity (Karler et al. , 
1974£,g). The excitatory properties may be significant in relation 
to the illicit use of marihuana by epileptics, for there is a poss1-
bility that excitatory effects may exacerba te epilepsy (Kee ler and 
Reifler, 1967). Because CBD does not have either the psycho-
and/or cardiotoxicity of !l9 -THC, and 1s a relatively more selective 
9 
anticonvulsant than ~ -THC, C8D has been proposed as a potentially 
2 
useful antiepileptic (Karler and Turkanis 1 1976a). Furthermore, CBD 
appears to lack most, if not all, the excitatory liabilities of e.9-THC 
(Karler et al., 1974.s;!; Turkanis et al., 1974, 1977; Martin and 
Consroe, 1976; Feeney et ale I 1976; Smiley et al., 1978). 
Although both the anticonvulsant properties of CBD and the 
excitatory properties of 11 9 -THC have been recognized in a variety 
of test systems, only a few investigations have addressed the 
question of mechanism of action t (Corcoran et ale I 1973; Izquierdo 
and Orsingher, 1973; Wada et ale I 1975; Turkanis and Karler,1975 I 
1976). In the present work, the cobalt epilepsy model was selected 
for study because it provides a rapidly developing I reproducible I 
spontaneously firing I discrete focus that develops characteristic 
epileptic potentials in the electrocorticogram (Dow et ale I 1962; 
Colasanti et ale I 1974). The preparation permits the direct measure-
ment from a primary focus of spontaneously firing epileptic potentials 
in unrestrained, conscious animals. Measurements from the cobalt-
induced focus permit a study of the electrophysiological mechanisms 
of both the excitatory and anticonvulsant effects of the cannabinoids. 
METHODS 
Experimental Animals 
The studies were carried out with male Sprague-Dawley rats 
(140-170 gm). In order to mount permanent stainless-steel screw 
electrodes (0-80 I 1.6 mm, Plastic Products, Roanoke I Virginia) in 
the cranium, the animals were anesthetized with sodium pentobarbital 
(35-40 mg/kg administered intraperitoneally). Recording electrodes 
were stereotaxically positioned over both frontal cortices (3 mm 
anterior to bregma and 3 mm lateral to the midline) and over both 
parietal cortices (3 mm posterior to bregma and 3 mm lateral to the 
midline). In addition I two electrically connected reference-ground 
screw electrodes \vere inserted in the cranium: one over the cere-
bellum and the other over a frontal sinus. All electrodes were 
attached to a multipin Arnphenol connector and dental acrylic was 
used to fasten the connector to the head, to insulate the electrodes 
electrically I and to form a conventional pedestal on each rat's head. 
To induce an epileptic focus I a piece of cobalt wire I 1 mm in 
diameter and 1.5 mm in length I was positioned on the dura at the 
4 
time of electrode implantation (Colasanti et ale I 1974). The cobalt-
induced focus subsequently developed within 6-12 days. Control 
animals were prepared in a similar manner, except that the cobalt 
wire was omitted. 
Experimental Procedures and Equipment 
The experiments were carried out 6-19 days after cobalt implan-
tation; in the present study, focal epileptic potential frequency during 
pre-drug control periods had a mean and standard deviation of 27 ±. 8 
potentials/min. In order for a potential to be classified as a cobalt-
caused epileptic response, it had to exhibit clearly recognizable 
shapes, as depicted in Fig. 3, and in general it had to have an 
amplitude at least 2. 5-fold greater than that of the background elec-
trocorticogram. In support of these criteria for potential selection, 
the large amplitude potentials were readily abolished by ethosuximide 
(Figs. 1 and 2), as described by Dow et ala (1973) and Scuvee-Moreau 
et al. (1977). Some of the epileptic rats also exhibited jaw and 
limb clonus; such clonic activity was visually monitored throughout 
each experiment. 
During an experiment, the rat was unanesthetized, awake and 
unrestrained and placed in a clear acrylic cage (20 x 32 x 32 cm), 
which was kept within a shielded recording chamber. The electrocor-
ticograms were recorded differentially against a grounded reference 
electrode by high impedance capacitance-coupled preamplifiers and 
5 
a polygraph (Grass Instrument Company I modei 5). Although 
electrical activity v{as measured from each frontal and parietal 
electrode simul taneously I In the pre sent study I focal epileptic 
activity was directly recorded from a primary focus I which developed 
at the site of cobalt implantation in the left parietal cortex. Inde-
pendent foci in the contralateral cortex rarely occurred and rats 
wi th such foci were excluded. 
Drug Preparations 
Ultrasound was used to disperse 119_ THC I II-OH-1l 9-THC I CBD 
and phenytoin in isotonic saline solution with Tween 80 I as previously 
described (Turkanis et al. I 1974). Trimethadione I ethosuximide and 
pentylenetetrazol (PTZ) were dissolved in an isotonic saline-Tween 80 
solution; all drug and vehicle preparations contained a final concen-
tration of 3% T\t\'een 80 and were administered intraperitoneally. The 
injection volume I except for trimethadione and ethosuximide I was 
0.1 mlllOO g body wt; In the trimethadione and ethosuximide experi-
ments 0.2 mlllOO g body wt was used. Each animal was subjected 
to only one drug experiment in order to avoid the potential complica-
tions of drug interactions. 
RESULTS 
Time-effect Re lations 
The present study is an investigation of the influence 
of CBD and lP-THC relative to well-established antiepileptics 
on the frequency of cobalt-caused focal epileptic cortical potentials 
1n conscious rats. Before any pharmacological experiments were 
undertaken, however, the stability of the frequency of focal 
potentials was evaluated by continuously recording during the 
lBO-min test period in 7 vehicle control studies. The control study 
at the top of Fig. 1 illustrates the general experimental design: 
The first vehicle dose was administered 15 min after the beginning 
of the experiment; the second dose I 45 min after the first dose. 
Subsequently, the electrocorticograms were recorded for an addi-
tional 120 min. This time-effect relation seen in Fig. I, is 
representative of the 6 other control studies. In short, potential 
frequency provides a relatively stable parameter for the pharmaco-
logical evaluation of anticonvulsant drugs. 
The drug studie s in Fig. 1 were identical in de sign to the 
controls, except that a drug preparation was substituted for the 
FIG. 1. Influence of vehicle, t:. 9 -THe, ethosuximide and trimetha-
dione on the frequency of epileptic potentials at a cobalt-induced 
focus in the left parietal cortex. Each time-effect relation depicts 
the results from 1 animal; each pOint represents the mean frequency 
during a 5-min period. The arrows indicate the time of vehicle or 
drug administra.tion. 
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second vehicle dose. The time--effect relations of the 3 drugs 
indicate that substantial al terations in frequency occurred following 
drug administration: ~ 9 -THC markedly enha.nced the frequency of 
focal potentials, whereas bott~ ethosuximide and trimethadione 
reduced focal activity. Generally speaking, there were al so some 
similarities among the three drugs: In the majority of experiments I 
the drug responses began within IS min, persisted for at least 60 
min, and concluded within 120 min.. In a few experiments I the drug 
effects were still apparent at the end of the drug-test period. Time-
effect relations, such as those shown in Fig. I, were used to deter-
mine the maximum response produced by a drug dose; from the 
maximum response data, the dose--response relations illustrated 
in Fig. 2 were derived. 
Dose-effect Re lations 
The dose-effect relations shown in Fig. 2 included dose s tha t 
are known to exert anticonvulsant activity in various rat test systems: 
9 t:. -THe, 1-10 mg/kg (Corcoran et al., 1973; Consroe and Man, 1973; 
Karler et al., 1974d), CBD I 1- SO mg/kg (Izqu.ierdo and Tannhauser I 
1973; Karler and Turkanis, 1976~; Smiley et al., 1978), ethosuximide 
and trimethadione I 100-400 mg/kg (Goodman et ale I 1949; Dow et ale , 
1973) I and phenytoin, 5-10 mg/kg (Petty and Karler, 1965). As 
illustrated in Fig. 2 I ethosuximide diminished the frequency of 
focal po~entials in a dose·-related manner; although the data is not 
10 
Q 
FIG. 2. Influence of ethosuximide, phenytoin, !::. - -THe and CBD on 
the frequency of focal epileptic potentials at a cobalt-induced focus 
in the left parietal cortex. Each pOint represents the results from 1 
animal and is the maximum frequency expressed as a percentage of 
predrug control. The lines were calculated by least squares regres-
sion. 
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shown, trimethadione in additional experiments yie Ided ethosllxi-
mide-like results. Phenytoin, in contrast, exerted no suppressant 
effect on cobal t- induced epileptic potentials (Fig. 2). 
Q 
A'" -THC raised the frequency of focal potentials in a dose-
related fashion, while CBD, like phenytoin, had no effect (Fig. 2). 
The data indicate that CBD, 6. 9 -THC and phenytoin even in doses 
5-10 times greater than their anticonvulsant dose 50 values, as 
determined by the maximal electroshock test, did not display an 
ethosuximide-like decrease in frequency. Thus, the mechanism of 
the anticonvulsant action of the cannabinoid doe s not appear to 
involve the abolition of focal epileptic potentials. 
Focal Potential Frequency Increase and Bursts 
9 Caused by 6. -THC 
In the present investigation, 11 9 -THC, unlike CBD and 
phenytoin, greatly enhanced the frequency of focal potentials (Figs. 
1 and 2). Two different electrocorticographic phenomena at the focal 
recording si te were noted after 6. 9 - THC and both contributed to the 
overall increase in frequency: First,6. 9 -THC raised the frequency 
of cobalt--produced epileptic potentials at the focus (Fig. 3B1), but 
no epileptic potentials appeared at the other 3 recording sites (Fig. 
382, 3B3, 3B4). Because this drug response ~las confined to the 
Q 
focus, the data suggest that t,."--THC selectively activated the 
epileptic focus. 
13 
Secondly, another type of epileptic-like electrical potential 
contributed to the h 9 -THe-induced frequency increase. These 
potentials exhibited several features that distinguish them from the 
cobalt-induced spikes depicted in Fig. 3: First, they occurred in 
intermittent, discrete bursts of polyspikes (high voltage multiphasic 
potentials) (Fig. 4A-C); the modal duration of the bursts in 8 experi-
ments ranged from 1.5-4.0 sec. Secondly I the bursts resembled 
after-discharges (ADs) produced by focal electrical stimulation of 
the cortex (Racine I 1975); and, c~mpared with cobalt-induced spikes I 
the individual potentials within each burst exhibited a more symme-
trical shape than that of the focal potentials (Figs. 3 and 4). Thirdly, 
the bursts did not occur prior to trea tment but began to develop 45-
60 min after drug and persisted for the remainder of the 120-min 
test period (Fig. 5). Fourthly I the bursts were generalized pheno-
mena that were usually detectable from all 4 cortical recording sites. 
The bursts I however, did not appear to originate exclusively at the 
cobalt-induced focus because they were occasionally seen in one 
or moce of the non-focal electrocorticograms, while being absent at 
the focus. Finally I the bursts made a relatively small contribution 
to the ~ 9 - THC-caused increase in focal frequency: For example, 
over a range of 0.5-25 mg/kg cf 6,9- THC , the potentials associated 
wi th bursts amounted to less than 2% of the total number of epileptic-
like potentials recorded; at 50 and 100 mg/kg f they v\,rere 8.2 and 
FIG. 3. Influence of A 9 -THe on the electrocorticogram of an 
epileptic rat. The recordings were obtained 20 min after either 
vehicle or drug. Each dot below the focal recordings (AI and Bl) 
indicates an epileptic potential. 
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FIG. 4. AD-like bursts produced by !J. 9- THC I II-0H-A 9- THC and 
P1Z. Responses A, Band C were obtained 81-90 min after 
t:.9 -THC; responses D,E, and F I 15-60 min after 11-0H-A 9-THC ; 




FIG. 5. Time course of AD-like bursts produced by ~ 9- THC I 
11-0H-~ 9- THC and PTZ in epileptic rats. Each time-effect relation 
represents the results from 1 animal. Vehicle was given 15 min 
after the beginning of the control period; drug I at the beginning of 
120-min test period; an additional dose of PTZ (20 mg/kg) was 
given at 45 min. 
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18.0%, respectively. The findIngs also suggest that moderate burst 
production requires relatively high doses of A 9- THC • 
Other investigators have reported that marihuana extracts or 
ll~THC induced polyspikes in nornlal animals (Pirch et al. I 1972; 
see Truitt and Braude I 1975, for a review). Consequently, 10 
experiments were carried out with control rats (no cabal t focus) I 
and 119_ THC (1-100 mg/kg) caused polyspikes that were similar to 
those previously described by Pirch et al. (1972). The polys pikes 
were visually distinguishable from the cabal t- induced focal epileptic 
potentials and were always generalized and not focal in nature. 
9 Therefore I the data clearly demonstrate that A -THC did not induce 
focal potential s I such as tho se exhibited by a cobalt epileptic focu s . 
In contrast l many of the polyspikes in normal animals resembled the 
119 -THC-caused bursts in epileptic animals; however normal rats I 
unlike epileptic rats l often displayed so much variability in the 
shapes of these high voltage potentials that discrete bursts of poly-
spikes were frequently difficult to identify. Thus I the 11-0H-ll 9-THC 
and PTZ experiments described below were carried out in epileptic 
animals so that both focal phenomena and generalized bursts could 
be reliably measured. 
11-0H-t::. 9 -THe Studies 
A limited supply of 11-0H-A 9- THC I the major metabolite of 
[:.9 -THC, restricted the experiments to 3 animals and to a dosage 
21 
range of 10-20 mg/kg. In spite of such limitations, the studies 
provided a valuable comparison of the pharmacological properties of 
the metabolite and its parent compound. The II-OR metabolite, 
unlike IJ. ~TRC, did not produce a consistent effect on cobalt-caused 
focal epileptic potentials: an increase in frequency was found .tn 
one experiment, a decrease in another, and no change in the third. 
The lI-OH metabolite's dose may have been insufficient to cause 
an enhancement of the frequency of epileptic potentials. Raising 
the dose, however, was not possible because 20 mg/kg produced 
marked toxicity: For example, at this dose, the II-OH-1J.9-THC 
produced persistent circling behavior, which, under the conditions 
of the present investigation, did not occur with either t.9-THC or 
CBD. 
In addition, the II-OH compound (Fig. 4 D -F) produced 
generalized bursts, which were similar to those evoked by tP-THC. 
A major difference between the 2 drugs was the II-OH-metabolite's 
shorter onset time. Time-course data contrasting the differences in 
onset time beDlvreen the 2 drugs are illustrated in Fig. 5: II-OH-
6.9 -THC produced bursts in 15-30 min; !:,. 9- THC , in 45-60 min. 
PTZ Studies 
PTZ was included in the present investigation as a reference 
drug, because 1J.9_ THC and PTZ are known to exert similar central 
22 
excitatory responses in some electrophysiological test systems 
(Boyd et al., 1971a, 12, 1974; Turkanis et al., 1977). PTZ experi-
ments were carried out in a manner identical to that of the other 
drug studies I except that multiple doses of PTZ were usually 
administered during each experiment due to its relativeiy short 
9 duration of action. PTl, unlike t::. -THC I se ldom enhanced focal 
activity: In 5 multi-dose experiments, PTZ in subconvulsant doses 
(10-40 mg/kg) only augmented focal frequency once. In contrast, 
PTZ, like t::.9-THC and 11-0H-t::.9-THC, consistently produced 
generalized bursts, such as those seen in Fig. 4G-1. The time 
course of PTZ-caused bursts (Fig. 5) illustrates PTZ's rapid onset of 
action. 
The data suggest that the bursts of polyspikes produced by 
t::. 9-THC or its 11-0H metabolite are manifestations of their central 
excitatory properties: First, these cannabinoids elicited generalized 
bursts similar to those produced by the central excitatory drug, PTZ. 
Secondly, the bursts caused by all 3 drugs resemble electrically 
evoked cortical ADs (Racine, 1975). Neither CBD nor phenytoin I 
even in high doses, induced any !::.9-THC-like bursts; therefore, the 
9 
major difference among the effects of CBD, phenytoin and!::. -THC in 
cobalt induced epileptic animals I as well as in other test systems 
(Karler et al., 1974d; Turkanis et al., 1974, 1977), is t::.9-THC' s 
CNS excita tion. 
23 
Influence of the Cannabinoids on r-...1otor Seizure s 
A comprehensive study of the drug influence on convulsions 
was not feasible I because only a small number of the epileptic rats 
dis91ayed limb and jaw clonus. Al though there are too fevv observa-
tions from ethosuximide, trimethadione and phenytoin experiments 
to warrant discus sion, the vehicle and cannabinoid studie s did 
provide valuable information: In 7 vehicle control experiments I 4 
rats exhibited clonic activity throughout the 180-min test and 
vehicle treatment did not alter or induce convulsions in any of the 
control rats. In 8 bo9-THC studies, I animal during the predrug 
control period displayed clonus, which was exacerbated by 100 
mg/kg of f.9- THC . Three other animals developed perSistent clonic 
9 
activity only after treatment with f. -THC (25 or 50 mg/kg). In 
contrast, in 8 experiments I CBD in doses of 1-50 mg/kg abolished 
seizures in the 4 rats that exhibited clonus and CBD in doses as 
high as 200 mg/kg did not produce convul sions in any of the 
ep.ileptic rats. The data suggest that CBD abolished seizures with--
out affecting the focal abnormality; consequently I CBD may produce 
its anticonvulsant effect by depressing seizure spread within the 
9 CNS. In contrast, bo -THC exacerbated both the electrical and 
motor manifestations of cobalt-caused epilepsy. 
DISCUSSION 
The re suI ts of the cannabinoid experiments on a cobalt-
induced epileptic focus in the rat parietal cortex have provided 
information relative to the mechanism of the anticonvulsant action 
of CBD 1 as well as the potential toxicity of t:. ~THC. De spite 't"'1e 
well-documented anticonvulsant activity of D. ~THC (Karler and 
Turkanis, 19 76S!) I the drug produced several CNS exci ta tory effects: 
It increased the frequency of focal epileptic potentials; it produced 
generalized bursts of epileptic-like polyspikes; and finally I it 
caused frank seizures. None of these excitatory effects were 
associated with CBD I even in very high doses . 
.19-THC's excitatory properties have been described previously; 
for example I A ~THC exacerbated PTZ-caused minimal seizure s 
(Karler et al. I 1974.9.) I caused withdrawal hyperexcitability in the 
6 - Hz and 60 - Hz e Ie c tro s ho c k te s t s (Tur ka n i set a I . I 1978), pro-
longed electrically evoked hippocampal ADs ne yet a 1 . 1 19 73) I 
enhanced electrically evoked cortical potentials (Boyd et ale I 1971a, 
QI 1974), augmented photically evoked cortical ADs (Turkanis et al. , 
1977) and produced convulsions in epHeptic beagles (Feeneyetal. /1976), 
25 
in a special strain of rabbits (I.Aartin and Consroe, 1976), as well 
as in normal rats (Stadnicki et al., 1974). The mechanism of the 
eNS excitation is not known; however, the present data demonstrate 
that b.~THC directly activates an epileptic focus, which, in turn, 
suggests that marihuana may exacerbate certain focal epilepsies 
and would, therefore, be contraindicate d in e pile ptic s . There is 
one report in the literature linking the use of marihuana to the 
precipi tation of grand mal seizure s in a Single pa tient (Kee ler and 
Reifler, 1967), but in another patient, marihuana smoking enhanced 
the antiepileptic activity of phenobarbital and phenytoin (Consroe 
et al. I 1975). The diversity of these very limited clinical observa-
tions may reflect the complexity of b. 9-THC's known effects in 
animals: The drug not only produce s numerous excita tory effects I 
but it also effectively blocks seizures in certain types of anti-
seizure tests (Karler and Turkanis, 1976~, b). 'V'lhether the use of 
marihuana by epileptics will affect seizure control, remains to be 
determined; nevertheless I epileptic patients should be made aware 
of the potential hazards. 
9 
The investigation of the excitatory properties of !J. -THC was 
9 
extended to its principal metabolite I 11-hydroxy-~ -THe. The only 
consistent excitatory effect evoked by this meta!:>olite was the pro-
duction of the generalized epileptic"-like bursts of polyspikes. The 
onset time of the effect (Fig. 5) \lvas shorter in the case of the 
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metabolite than it was in the parent compound. The difference in 
o 
onset time may indicate that the polyspike effect of t. oJ -THC is 
caused I at least in part I by its primary metaboli te I which vivo 
is very rapidly produced (Kader and Turkanis I 1976~). Conversely I 
the limited excitatory response to the II-hydroxy derivative is 
evidence that the other excitatory effects of 1::. 9 -THC, an increase in 
focal epileptic potentials and frank seizures I are a consequence of 
A 9- THC itself," The recorded excitatory effects of the II-hydroxy 
compound add to the accumulated evidence that some properties 
attributed to ~9 -THC may be related to the production of active meta-
bolites (Grunfeld and Edery I 1969; Brady and Carbone 1 1973; Gill et al., 
1973; Karler et al. 1 1974.£; Turkanis and Karler I 1975 I 1976; Kader and 
Turkanis, 1976~). 
The use of the cobalt epilepsy model offers a test system that 
lends itself to a mechanistic study of anticonvulsant effects. The 
differential effects of ethosuximide, trimethadione and phenytoin on 
the frequency of focal potentials confirm the observations of Dow 
et a1. (1973) and Scuvee-Moreau et al. (1977) and support the 
hypothesis that pharmacological inVestigation of cobalt-caused 
focal potentials may help to identify potentially useful drugs for the 
treatment of absence seizures. Previous studies of CBD have empha-
sized the Similarity between its anticonvulsant properties and those 
of phenytoin (Karler and Turkanis I 1975~, .2); however I there is S0me 
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evidence that CBD has ethosuximide-like properties (Smiley et al. , 
1978). In the cobalt model, CBD I unlike ethosuximide, did not 
seizures (Goodman and Lih, 1941; Karler et al., 1974d); It can pro-
long electrically evoked ADs (Gangloff and Monnier, 1957); and it 
can produce frank convulsions (Gruber et al., 1940). None of these 
excitatory effects was characteristic of CSD, even in very high 
doses (Karler et aL, 1974g; Slniley et al., 1978.) There are only 
two reports of excitatory effects related to CBD, and both studies 
lacked proper controls (Perez-Reyes and V/ingfield, 1974; Segal, 
1974). 
The excitatory effects of phenytoin are not unique for an 
ant1epileptic because others I such as phenobarbital, ethosuximide 
and trimethadione I also exhibit excitatory effects (Dow et ale I 
1973; Littrow et al. I 1970; Gangloff and Monnier, 1957). The CNS 
excitatory effects of these antiepileptics may contribute to their 
clinical toxicity I as evidenced by the ability of phenytoin to trigger 
absence seizures and ethosuximide to precipitate grand mal seizures 
(Woodbury and Fingl, 1975; Lorentz De set a 1. I 19 64) . If the 
hypothesis is correct that the excitatory effects of antiepileptics 
account for their exacerbation of certain types of seizures, then CBD I 
which appears to have little or no excitatory properties, may have a 
therapeutic advantage over some antiepileptics. 
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